GO
Loading...

Gilead Sciences Inc

More

  • Final Glance: Biotechnology companies Tuesday, 25 Nov 2014 | 6:57 PM ET

    Amgen Inc. fell $1.94 or 1.2 percent, to $162.24. Biogen Idec fell $1.34 or. 4 percent, to $305.40. Celgene Corp. rose$. 09 or. 1 percent, to $111.07.

  • Most active Nasdaq-traded stocks Tuesday, 25 Nov 2014 | 1:18 PM ET

    Apple Inc. fell. 8 percent to $117.66 with 38,369,600 shares traded. Cisco Systems Inc. rose. 7 percent to $27.22 with 14,180,100 shares traded. Facebook Inc. rose 1.6 percent to $75.20 with 18,544,700 shares traded.

  • Midday Glance: Biotechnology companies Tuesday, 25 Nov 2014 | 1:17 PM ET

    Amgen Inc. fell $1.86 or 1.1 percent, to $162.32. Biogen Idec fell $2.53 or. 8 percent, to $304.21. Celgene Corp. fell$. 15 or. 1 percent, to $110.83.

  • Early Glance: Biotechnology companies Tuesday, 25 Nov 2014 | 10:22 AM ET

    Amgen Inc. fell $2.11 or 1.3 percent, to $162.07. Biogen Idec fell$. 12 or percent, to $306.62. Celgene Corp. fell$. 35 or. 3 percent, to $110.63.

  • Final Glance: Biotechnology companies Monday, 24 Nov 2014 | 6:08 PM ET

    Amgen Inc. rose $1.37 or. 8 percent, to $164.18. Biogen Idec rose $3.19 or 1.1 percent, to $306.74. Celgene Corp. rose $2.78 or 2.6 percent, to $110.98.

  • Most active Nasdaq-traded stocks Monday, 24 Nov 2014 | 1:26 PM ET

    American Realty Capital Properties Inc. rose. 5 percent to $9.04 with 17,481,400 shares traded. Apple Inc. rose 1.9 percent to $118.63 with 45,726,300 shares traded. Ariad Pharmaceuticals Inc. rose 9.7 percent to $7.15 with 16,632,100 shares traded.

  • Early Glance: Biotechnology companies Monday, 24 Nov 2014 | 10:26 AM ET

    Amgen Inc. rose $2.73 or 1.7 percent, to $165.54. Biogen Idec rose $3.62 or 1.2 percent, to $307.17. Celgene Corp. rose $2.12 or 2.0 percent, to $110.32.

  • Final Glance: Biotechnology companies Friday, 21 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose$. 13 or. 1 percent, to $162.81. Biogen Idec rose $4.45 or 1.5 percent, to $303.55. Celgene Corp. rose$. 85 or. 8 percent, to $108.20.

  • Early Glance: Biotechnology companies Friday, 21 Nov 2014 | 10:17 AM ET

    Amgen Inc. fell$. 16 or. 1 percent, to $162.52. Biogen Idec rose $3.56 or 1.2 percent, to $302.66. Celgene Corp. rose $1.30 or 1.2 percent, to $108.65.

  • Final Glance: Biotechnology companies Thursday, 20 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose$. 04 or percent, to $162.68. Biogen Idec fell $4.51 or 1.5 percent, to $299.10. Celgene Corp. rose$. 37 or. 3 percent, to $107.35.

  • Midday Glance: Biotechnology companies Thursday, 20 Nov 2014 | 2:49 PM ET

    Amgen Inc. rose $1.79 or 1.1 percent, to $164.43. Biogen Idec fell $1.84 or. 6 percent, to $301.78. Celgene Corp. rose$. 60 or. 6 percent, to $107.58.

  • Early Glance: Biotechnology companies Thursday, 20 Nov 2014 | 10:29 AM ET

    Amgen Inc. rose$. 44 or. 3 percent, to $163.08. Biogen Idec fell$. 30 or. 1 percent, to $303.31. Celgene Corp. fell$. 16 or. 2 percent, to $106.82.

  • Nov 20- Global pharmaceutical spending will break the trillion dollar mark in 2014, driven by high prices in the United States for novel treatments such as Gilead Sciences Inc's Sovaldi for hepatitis C and new cancer drugs, according to a study released on Thursday. Total spending on drugs will hit $1.06 trillion, an increase of 7 percent over 2013 levels,...

  • Final Glance: Biotechnology companies Wednesday, 19 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose$. 40 or. 2 percent, to $162.64. Biogen Idec fell $1.95 or. 6 percent, to $303.61. Celgene Corp. rose$. 20 or. 2 percent, to $106.98.

  • Midday Glance: Biotechnology companies Wednesday, 19 Nov 2014 | 1:31 PM ET

    Amgen Inc. rose$. 39 or. 2 percent, to $162.63. Biogen Idec fell $1.63 or. 5 percent, to $303.93. Celgene Corp. rose$. 79 or. 7 percent, to $107.57.

  • Early Glance: Biotechnology companies Wednesday, 19 Nov 2014 | 12:00 PM ET

    Amgen Inc. fell $1.18 or. 7 percent, to $161.06. Biogen Idec fell $1.69 or. 6 percent, to $303.87. Celgene Corp. fell$. 80 or. 7 percent, to $105.98.

  • Final Glance: Biotechnology companies Tuesday, 18 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose $3.10 or 1.9 percent, to $162.24. Biogen Idec rose $3.14 or 1.0 percent, to $305.56. Celgene Corp. rose $2.42 or 2.3 percent, to $106.78.

  • Actavis Plc, Gilead Sciences and other biotechs were among the biggest drivers, a day after Allergan agreed to be bought by Actavis. Shares of Actavis were up 8.7 percent at $269.60, helped by bullish analyst notes, while Gilead's stock rose 3.3 percent to $103.71 percent. "A little bit of a risk trade is coming back on, and those are the areas for the M&A," said Uri...

  • Actavis Plc, Gilead Sciences, Celgene and other biotech names were among the S&P 500' s biggest drivers, a day after Allergan agreed to be bought by Actavis. The S&P health care index was up 1.6 percent, while shares of Actavis were up 8.3 percent, Gilead's rose 3.3 percent and shares of Celgene were up 2.4 percent. Helping Actavis were bullish analyst notes.

  • Most active Nasdaq-traded stocks Tuesday, 18 Nov 2014 | 1:25 PM ET

    Apple Inc. rose 1.3 percent to $115.47 with 41,708,500 shares traded. Cisco Systems Inc. rose. 5 percent to $26.59 with 26,839,200 shares traded. Dendreon Corp. fell 13.6 percent to$. 13 with 20,747,200 shares traded.